investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Country: Ireland ↑0.21   Healthcare ↑0.89   Biology ↑0.89 «See more»   Biopharma ↑1.84   Disease: Cardiovascular ↑2.84   Medicine ↑3.32

Disease: Cardiovascular stock segment: trending tickers

AMRN Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share 0.21% 0.21% 0 + Country: Ireland, Medicine, Disease: Cardiovascular

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1551182/000114036126008836/0001140361-26-008836-index.htm
8-K - Eaton Corp plc (0001551182) (Filer)
+ My List
CYTK Cytokinetics, Incorporated - Common Stock 1.74% 1.74% 0 + Medicine, Disease: Cardiovascular

Last highlighted: 10-K Sec report https://www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
10-K - CYTOKINETICS INC (0001061983) (Filer)
+ My List
ESPR Esperion Therapeutics, Inc. - Common Stock 1.84% 1.84% 0 + Medicine, Biopharma, Disease: Cardiovascular

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1434868/000162828026023196/0001628280-26-023196-index.htm
8-K - Esperion Therapeutics, Inc. (0001434868) (Filer)
+ My List
QTRX Quanterix Corporation - Common Stock 0.89% down 1.19% -0.3 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1503274/000150327426000011/0001503274-26-000011-index.htm
8-K - Quanterix Corp (0001503274) (Filer)
+ My List
CVRX CVRx, Inc. - Common Stock 9.5% 9.5% 0 + Disease: Cardiovascular, Medicine

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1376139/000137613926000016/0001376139-26-000016-index.htm
8-K - CVR ENERGY INC (0001376139) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.